SEATTLE, Aug. 4, 2022 /PRNewswire/ -- Volpara Health Technologies ("Volpara," "the Group," or "the Company"; ASX: VHT), a global health technology software leader providing an integrated platform for ...

Add articles to your saved list and come back to them anytime. The effectiveness of mammograms has long been key problem in public health programs for women. Often potentially cancerous tissue is ...

LYNNWOOD, Wash., March 15, 2024 /PRNewswire/ -- Volpara Health Technologies Ltd. (ASX: VHT), a global leader in software for the early detection and prevention of cancer, will showcase its latest ...

With FDA clearance, comprehensive reimbursement, and a proven track record, Optellum helps providers identify more cancers at an earlier stage and make well-informed decisions on patient management ...

Volpara software and research paves the way for automated, optimized and personalized care CHICAGO, Nov. 22, 2023 /PRNewswire/ -- Volpara Health Technologies Ltd. (ASX: VHT), a global leader in ...

Research Being Presented at ECR Demonstrates how VolparaEnterprise Software Helps Breast Imaging Providers Deliver High-Quality, Personalised Breast Screening VIENNA, March 1, 2017 /PRNewswire/ ...

CHICAGO, Nov. 30, 2022 /PRNewswire/ -- At the 2022 Radiological Society of North America (RSNA) Annual Meeting, Peter R. Eby, MD, of Virginia Mason Medical Center presented the results of the largest ...

In morning trade the Volpara Health Technologies Ltd (ASX: VHT) share price has charged higher following the announcement of a new sales agreement. At the time of writing the medical technology ...

Volpara health Technologies Ltd. (ASX: VHT), a global leader in software for the early detection and prevention of cancer, will showcase its latest software advancements for breast centers at the 2024 ...